跳转至内容
Merck
CN

247499

乙基纤维素

viscosity 100 cP, 5 % in toluene/ethanol 80:20(lit.), extent of labeling: 48% ethoxyl

登录 查看组织和合同定价。

选择尺寸


关于此项目

化学文摘社编号:
UNSPSC Code:
12162002
NACRES:
NA.23
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

乙基纤维素, viscosity 100 cP, 5 % in toluene/ethanol 80:20(lit.), extent of labeling: 48% ethoxyl

SMILES string

O1[C@H](C(C(C(C1COCC)OCC)OCC)OCC)O[C@@H]2C(OC(C(C2OCC)OCC)OCC)COCC

InChI

1S/C28H54O11/c1-9-29-17-19-21(31-11-3)23(32-12-4)26(35-15-7)28(38-19)39-22-20(18-30-10-2)37-27(36-16-8)25(34-14-6)24(22)33-13-5/h19-28H,9-18H2,1-8H3/t19?,20?,21?,22-,23?,24?,25?,26?,27?,28+/m1/s1

InChI key

MINRZDZESGXKDM-OLIDUAMRSA-N

form

powder or granules

autoignition temp.

698 °F

concentration

48.0-49.5%

extent of labeling

48% ethoxyl

refractive index

n20/D 1.47 (lit.)

viscosity

100 cP, 5 % in toluene/ethanol 80:20(lit.)

transition temp

softening point 155 °C

density

1.14 g/mL at 25 °C (lit.)

Quality Level

正在寻找类似产品? 访问 产品对比指南

Application

乙基纤维素可用于:
  • 制备甲草胺和异丙甲草胺的高分子微胶囊并研究其控制释放性能。
  • 作为合成双相药物释放纳米纤维的核心基质。
  • 制备具有优异漂浮和缓释能力的蜡基固体分散颗粒。

General description

乙基纤维素是一种无毒,生物体惰性,性质稳定的疏水聚合物。它可广泛用于制备药物传递系统的持续释放基材。

存储类别

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Päivi Grönroos et al.
Sensors (Basel, Switzerland), 19(12) (2019-06-30)
Novel hot electron-emitting working electrodes and conventional counter electrodes were created by screen printing. Thus, low-cost disposable electrode chips for bioaffinity assays were produced to replace our older expensive electrode chips manufactured by manufacturing techniques of electronics from silicon or
Robert Morhard et al.
IEEE transactions on bio-medical engineering, 67(8), 2337-2348 (2019-12-17)
Ethanol ablation, the injection of ethanol to induce necrosis, was originally used to treat hepatocellular carcinoma, with survival rates comparable to surgery. However, efficacy is limited due to leakage into surrounding tissue. To reduce leakage, we previously reported incorporating ethyl
Tetsuya Ozeki et al.
Biological & pharmaceutical bulletin, 35(11), 1926-1931 (2012-11-06)
Production of drug nanoparticles is an effective strategy to enhance solubility and oral absorption of water-insoluble drugs. The handling of drug nanoparticles has been an important issue in drug formulation because nanoparticles easily aggregate each other and redispersion of these
Kifayat Ullah Shah et al.
TheScientificWorldJournal, 2012, 842348-842348 (2012-06-01)
The design and fabrication of sustained/controlled release dosage forms, employing new excipients capable of extending/controlling the release of drugs from the dosage forms over prolonged periods, has worked well in achieving optimally enhanced therapeutic levels of the drugs. In this
Oguzhan Gunduz et al.
Pharmaceutical research, 30(1), 225-237 (2012-09-08)
To investigate a new microfluidic method for the continuous preparation of hollow-shell nanoparticles of a hydrophobic polymer and the simultaneous encapsulation within these of a hydrophilic active pharmaceutical ingredient. A specially designed and constructed microfluidic device which facilitates at a

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持